Catalyst is helping establish the University of California Drug Discovery Consortium, an effort across the UC system’s five medical campuses—UC Davis, UC Irvine, UCSF, UCLA & UC San Diego—to figure out ways to work together to speed the development of potentially life-saving therapies. Tralau-Stewart is principal investigator on a $2.2 million, three-year grant from UC’s Multicampus Research Programs & Initiatives focusing on early translation of academic discovery research into therapies.
